Full Text View
Tabular View
No Study Results Posted
Related Studies
Topical Alprostadil for Female Sexual Arousal Disorder
This study has been completed.
Study NCT00324948   Information provided by VIVUS, Inc.
First Received: May 9, 2006   Last Updated: March 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sexual Dysfunction, Physiological
Additional conditions recognized in this trial
Sexual Dysfunctions, Psychological
More general conditions related to this trial
Genital Diseases, Female
Genital Diseases, Male
Mental Disorders
Sexual and Gender Disorders
Interventions listed in this trial
Topical alprostadil (PGE-1)
Additional drug interventions recognized in this trial
Alprostadil
More general drug interventions related to this trial
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Platelet Aggregation Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
VIVUS, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services